BIOSANTE PHARMACEUTICALS INC 4
4 · BIOSANTE PHARMACEUTICALS INC · Filed Apr 19, 2005
Insider Transaction Report
Form 4
LEHMAN LEAH M
VP, Product Development
Transactions
- Sale
Common Stock
2005-04-18$3.78/sh−6,900$26,082→ 56,500 total - Sale
Common Stock
2005-04-19$3.72/sh−1,500$5,580→ 34,600 total - Sale
Common Stock
2005-04-15$4.02/sh−377$1,516→ 80,000 total - Sale
Common Stock
2005-04-19$3.80/sh−400$1,520→ 4,900 total - Sale
Common Stock
2005-04-19$3.71/sh−900$3,339→ 36,100 total - Sale
Common Stock
2005-04-19$3.77/sh−7,800$29,406→ 10,500 total - Sale
Common Stock
2005-04-19$3.75/sh−6,800$25,500→ 25,300 total - Sale
Common Stock
2005-04-19$3.76/sh−7,000$26,320→ 18,300 total - Sale
Common Stock
2005-04-19$3.73/sh−1,000$3,730→ 33,600 total - Sale
Common Stock
2005-04-18$3.76/sh−4,800$18,048→ 68,700 total - Sale
Common Stock
2005-04-18$3.79/sh−6,100$23,119→ 50,400 total - Sale
Common Stock
2005-04-18$3.80/sh−6,700$25,460→ 43,700 total - Sale
Common Stock
2005-04-18$3.77/sh−5,300$19,981→ 63,400 total - Sale
Common Stock
2005-04-19$3.82/sh−4,900$18,718→ 0 total - Sale
Common Stock
2005-04-19$3.78/sh−5,200$19,656→ 5,300 total - Sale
Common Stock
2005-04-18$3.74/sh−200$748→ 79,800 total - Sale
Common Stock
2005-04-18$3.75/sh−6,300$23,625→ 73,500 total